We could not find clinical DAT imaging studies that assessed the effects of these drugs on DAT binding. Anticholinergic drugs, such as benztropine or trihexy- phenidyl, are frequently used, particularly in young parkin- sonian patients, and cholinesterase inhibitors are frequently used in demented ...